Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate-Reference-Cited by-同舟云学术

Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate

Published:2008-03-27 Issue:4 Volume:58 Page:953-963
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Kremer Joel M.,Genant Harry K.,Moreland Larry W.,Russell Anthony S.,Emery Paul,Abud-Mendoza Carlos,Szechiński Jacek,Li Tracy,Teng Julie,Becker Jean-Claude,Westhovens René

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference30 articles.

1. Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis: an observational study;Aletaha;J Rheumatol,2002

2. Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis: an evaluation based on a 1-year randomised controlled trial;Maetzel;Pharmacoeconomics,2002

3. Rheumatoid arthritis: an overview of new and emerging therapies;Doan;J Clin Pharmacol,2005

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors contributing to the improvement in Japanese Health Assessment Questionnaire after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long-term, observational, multicentre study in Japan (ORIGAMI);Modern Rheumatology;2024-05-10

2. Different Effects of Biologics on Systemic Bone Loss Protection in Rheumatoid Arthritis: An Interim Analysis of a Three-Year Longitudinal Cohort Study;Frontiers in Immunology;2021-12-20

3. Biologic Agents and Secondary Immune Deficiency;Immunology and Allergy Clinics of North America;2021-11

4. Terapias células T alvo (anti-CD80/86);Revista Paulista de Reumatologia;2021-09-30

5. Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis;Open Access Rheumatology: Research and Reviews;2021-06